Many studies proved the prognostic value of serum albumin and lymphocytes in malignant tumors: lower albumin levels were linked to poor prognosis for cancer patients (13, 18), and high levels of lymphocytes may indicate a better prognosis (19–21). Here, ALB is linked to cancer.